The war against influenza: discovery and development of sialidase inhibitors

No Thumbnail Available
File version
Author(s)
von Itzstein, Mark
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2007
Size
File type(s)
Location
License
Abstract

The threat of a major human influenza pandemic, in particular from highly aggressive strains such as avian H5N1, has emphasized the need for therapeutic strategies to combat these pathogens. At present, two inhibitors of sialidase (also known as neuraminidase), a viral enzyme that has a key role in the life cycle of influenza viruses, would be the mainstay of pharmacological strategies in the event of such a pandemic. This article provides a historical perspective on the discovery and development of these drugs - zanamivir and oseltamivir - and highlights the value of structure-based drug design in this process.

Journal Title
Nature Reviews Drug Discovery
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Biological sciences
Biomedical and clinical sciences
Persistent link to this record
Citation
Collections